The James Esparza Law Firm
Product Liability Lawyers
Salt Lake City, Utah
Enbrel
Please Note: The pharmaceutical liability attorneys at the James Esparaza law firm have represented countless clients in the Utah area who have been harmed by dangerous drugs, and we can help you, too. However, at this time, we are only accepting pharmaceutical liability cases for the following drugs: Levaquin, Yaz and Yasmin, and Transvaginal Mesh Patches. The link here indicates the drug cases we are no longer accepting so that we may focus our time and resources on victims who have been harmed by Levaquin, Yaz/Yasmin and the Transvaginal patches.
The U.S. Food and Drug Administration (FDA) approved Enbrel in 1998 primarily for the treatment of rheumatoid arthritis. Shortly after its release, however, Immunex – the manufacturer of Enbrel – began hearing reports of serious side effects from those patients taking the prescribed dosage of Enbrel.
Immunex stated in a letter to healthcare professionals that, “Rare cases of central nervous system disorders such as multiple sclerosis, myelitis and optic neuritis have been reported in patients with rheumatoid arthritis who have received Enbrel therapy.” Unfortunately, at least eleven cases of nervous system disorders have been reported to date, with another ten cases of blood-cell shortages that severely increases the risk of fatal infections.
Potentially dangerous side effects related to the use of Enbrel include:
- Serious blood reactions
- Nervous system disorders
- Multiple Sclerosis
- Myelitis
- Optic Neuritis
- Pancytopenia, including aplastic anemia
